Analysts name 3 stellar ASX growth shares to buy right now

These growth shares have been named as buys by analysts…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors searching for growth shares, might want to look at three named below.

Here's why analysts rate these ASX growth shares as buys right now:

Appen Ltd (ASX: APX)

The first growth share to look at is Appen. The shares of this leading developer of high-quality, human annotated datasets for machine learning and artificial intelligence (AI) have recently hit a multi-year low. This has been driven by concerns over softening demand for its services during the pandemic. While this is disappointing, one leading broker remains confident on the company's future and expects demand to pick up. As a result, it appears to see this pullback as a buying opportunity for investors. That broker is Citi. It currently has a buy rating and $18.80 price target on the company's shares.

Breville Group Ltd (ASX: BRG)

Another ASX growth share to look at is Breville. This leading appliance manufacturer has been growing at a strong rate over the last few years and continued this positive form in FY 2021. Last month the company revealed a significant lift in both sales and profits. This was driven by strong demand, recent acquisitions, its international expansion, and its continued investment in research and development. The latter ensures that Breville has a strong and innovative product portfolio. The team at Morgans appears confident that Breville's growth can continue for the foreseeable future. As a result, its analysts currently have an add rating and $34.00 price target on its shares.

PointsBet Holdings Ltd (ASX: PBH)

A final growth share to look at is PointsBet. It is a sports wagering operator and iGaming provider with operations in the ANZ and US markets. PointsBet has been growing at a rapid rate over the last couple of years thanks to the popularity of its innovative sports betting products and services and the shift to mobile betting from stores. The latter has increased accessibility and opened the market up to other demographics. Goldman Sachs is expecting its strong growth to continue in the future. In light of this, the broker currently has a buy rating and $14.75 price target on its shares.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended Appen Ltd and Pointsbet Holdings Ltd. The Motley Fool Australia owns shares of and has recommended Appen Ltd. The Motley Fool Australia has recommended Pointsbet Holdings Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A man in a suit smiles at the yellow piggy bank he holds in his hand.
Share Market News

Forget Westpac shares, these ASX ETFs could be better buys

Here's why these funds could be quality picks for investors looking for alternatives to the banks.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another tough day for investors.

Read more »

Rising real estate share price.
REITs

Macquarie names its top 4 ASX REITs to buy today

Macquarie expects these four dividend paying ASX REITs will all surge higher in 2026.

Read more »

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

Man with virtual white circles on his eye and AI written on top, symbolising artificial intelligence.
Broker Notes

Why this ASX AI stock could return 40% in 2026

Let's see which stock Bell Potter is tipping to rise strongly.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Share Market News

Analysts name 2 top ASX 200 shares to buy today

Leading investment experts name two quality ASX 200 shares to buy now.

Read more »

Woman leaping in the air and standing out from her friends who are watching.
Broker Notes

This ASX 200 gold stock has surged 77% in 2025. Here's why Macquarie expects it to leap another 23%

Macquarie forecasts 23% upside for this surging ASX gold stock, and that doesn’t include the dividends!

Read more »